YFY Biotech Management Company
About Us
Company Profile
Management Team
Capital Funds
Portfolio
News
Contact Us
繁體
English
News
SEARCH
Year
2024
2023
2022
2021
2020
2019
2018
2017
Jul 6, 2017
Mycenax hosted business visitors from JPMA
READ MORE
Jul 4, 2017
Mycenax presented new technology platforms for biologics process development and update pipelines in Taiwan Bio 2017
READ MORE
Jun 30, 2017
FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
READ MORE
Jun 20, 2017
USFDA approved LT3001 AIC trial
READ MORE
Jun 19, 2017
Mycenax To Attend BIO 2017 In San Diego
READ MORE
Jun 15, 2017
Mycenax To Attend BIOtech Japan 2017 In Tokyo
READ MORE
Jun 7, 2017
TaiGen Beijing Ltd Obtained its 49% Stake in Joint Venture and Completed the 9% Equity Sales to HEC
READ MORE
May 30, 2017
TaiGen Announces Submission of NDA for Taigexyn Intravenous Formulation to China FDA
READ MORE
prev
1
2
3
4
5
next
YFY Biotech Management Company